Off-the-shelf stem cell therapy for type 1 diabetes yields more positive results
statnews.com · 204 words · saved by 1 readers
An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.
Twelve people with type 1 diabetes who received an investigational off-the-shelf stem cell therapy were able to produce their own insulin and keep healthy blood glucose levels for at least one year, Vertex Pharmaceuticals said Friday. After three months, none of them suffered severe bouts of low blood sugar. After 12 months, out of the 12 participants, 10 no longer needed to inject insulin. The study, presented Friday at the American Diabetes Association’s scientific meeting and simultaneously published in the New England Journal of Medicine, updates previous research that followed these…
saved by
related reading
- Chinese Scientists Transplant Stem Cell-derived Islets to Treat Type 1 Diabetesenglish.cas.cn
- Scientists track cellular disruptions that lead to type 1 diabetesstatnews.com
- Stem cells reverse woman’s diabetes — a world firstnature.com
- Sanofi Tzield: The 200 Best Inventions of 2023 | TIMEtime.com
- World-first: therapy to make cells young again trialled in a personnature.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- A Potential Dramatic Change in Treating Type 1 Diabetes - Jacobs School of Medicine and Biomedical Sciences - University at Buffalomedicine.buffalo.edu
- Weekly Dose of Optimism #96notboring.co
- Medicine's Endgamenotboring.co
- Understanding Cell + Gene Therapypatienteducation.asgct.org
- Conception | Advancing the Future of Fertilityconception.bio
- Pearl Freier on X: "Cell & gene therapies were 2.5x more likely to receive FDA approval after entering Phase 1 than other drug types according to research by the NEWDIGs initiative at Tufts Medical Center h/t @DrPHanley & @alliancerm . @NatRevDrugDisc paper below 1/n https://t.co/DN4k7qWrAt" / Xx.com